Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.
Title X funds withheld due to diversity initiative crackdown, Politico reports.
Trump promotes IVF access while cutting the team responsible for tracking it.
Estrogen’s role in the brain goes far beyond reproduction, NYT reports.
The influential Women’s Health Initiative will shut down without federal support.
Cosmo breaks down Botox alternatives—and why your injector matters most.
Cancer incidence among women continues to rise despite overall progress.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
Study finds no mass OBGYN flight from states with abortion bans—yet.
ACOG proposes fewer but longer prenatal visits to improve care for low-risk pregnancies.
Cosmo breaks down Botox alternatives—and why your injector matters most.
Cancer incidence among women continues to rise despite overall progress.
Trump administration floats baby bonuses, fertility funding, and fertility-focused Fulbrights.
Study finds no mass OBGYN flight from states with abortion bans—yet.
ACOG proposes fewer but longer prenatal visits to improve care for low-risk pregnancies.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.
Most menopause-marketed products are rebranded basics—at luxury prices, says Women’s Health investigation.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.